Projected reductions in HPV-related cancer incidence, by gender.

Age-standardised incidence rates are expressed as 100,000 per individual and have not been adjusted for world population; rates under no vaccination scenario refer to current rates reported from the Cancer Registry of Norway [21]

Projections reflect the expected cancer reduction estimated from the dynamic transmission model for the last cohort to be vaccinated in this analysis. See Methods section for assumptions regarding vaccine efficacy against non-cervical cancers.

Projected reduction in risk of cervical cancer is estimated from the stochastic disease model and in the context of current cervical cancer screening compliance.